Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin-Lymphoma”

6,515 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,515 results

Early research (Phase 1)Study completedNCT01800838
What this trial is testing

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+4 more
Kevin Cooper MD 11
Testing effectiveness (Phase 2)Looking for participantsNCT06052826
What this trial is testing

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

Who this might be right for
B-Cell Non-Hodgkin LymphomaMultiple Myeloma
City of Hope Medical Center 164
Not applicableStudy completedNCT02461290
What this trial is testing

Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1

Who this might be right for
Follicular Lymphoma
Hoffmann-La Roche 99
Testing effectiveness (Phase 2)Study completedNCT00007982
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsHead and Neck CancerLymphoma
Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT00005959
What this trial is testing

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Amgen
Early research (Phase 1)Ended earlyNCT04973527
What this trial is testing

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 9
Early research (Phase 1)Enrolling By InvitationNCT06827782
What this trial is testing

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Who this might be right for
Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Testing effectiveness (Phase 2)Ended earlyNCT00275262
What this trial is testing

Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+1 more
Abbott 25
Not applicableUnknownNCT02474550
What this trial is testing

Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaNeutropenia, Febrile
Ajou University School of Medicine 1,000
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Not applicableLooking for participantsNCT06156774
What this trial is testing

SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Fondazione Italiana Linfomi - ETS 130
Testing effectiveness (Phase 2)Looking for participantsNCT05934513
What this trial is testing

GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Genfleet Therapeutics (Shanghai) Inc. 95
Testing effectiveness (Phase 2)UnknownNCT00807196
What this trial is testing

Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Maisonneuve-Rosemont Hospital 20
Not applicableStudy completedNCT01760915
What this trial is testing

University of Wisconsin Severe Asthma Research Program III

Who this might be right for
Asthma
University of Wisconsin, Madison 107
Testing effectiveness (Phase 2)Ended earlyNCT01745913
What this trial is testing

Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+2 more
Weill Medical College of Cornell University 2
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Testing effectiveness (Phase 2)Study completedNCT00002879
What this trial is testing

Cladribine in Patients With Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 51
Early research (Phase 1)Active Not RecruitingNCT01333046
What this trial is testing

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaHodgkin Disease
Baylor College of Medicine 36
Testing effectiveness (Phase 2)Study completedNCT00992446
What this trial is testing

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Diffuse Large B-Cell LymphomaB-Cell Non-Hodgkin LymphomaFollicular Lymphoma+3 more
Fred Hutchinson Cancer Center 27
Load More Results